This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Regence Selects Walgreens To Provide Specialty Infusion Medication Services For Members

Walgreens Infusion Services (NYSE: WAG) (Nasdaq: WAG) and Regence, an affiliation of health care plans in the Pacific Northwest/Mountain State region, recently entered into an agreement to help lower overall medical costs for specialty infusion patients in Idaho, Oregon, Utah and Washington. This site of care optimization program allows patients on specialty infusion medications to visit a Walgreens alternate treatment site or receive care in their home at a lower out-of-pocket cost. Specialty medications are used to treat chronic conditions including Crohn’s Disease, multiple sclerosis, rheumatoid arthritis and various blood disorders.

Depending on the drug prescribed to a patient, health plan cost savings of 30 percent to 70 percent can be possible when therapy is given at an alternate treatment site compared to other outpatient settings, according to Walgreens industry analysis of more than 5.3 million commercial managed care lives from January 2008 through December 2010. For Remicade ® (infliximab) and Immune Globulin–two high cost infusion drugs–the same data shows health plan costs are typically reduced by more than $20,000 per patient annually when provided at an alternate treatment site.

“We are focused on the patient and our goal is to deliver medications at the most cost effective and most clinically appropriate site of service,” said Mike Ellis, Walgreens vice president of specialty pharmacy and infusion. “Through this agreement with Regence, patients receiving high-cost specialty medications can receive treatment in their home, or in our alternate treatment sites. With our clinicians, expertise and multiple points of care, we are playing an important role in the health care continuum.”

“We have chosen to work with Walgreens as part of our ongoing effort to improve health outcomes while managing the total cost of care for our customers,” said Raulo Frear, Pharm D, general manager of RegenceRx. “We particularly value their expertise in working directly with patients to help ensure they have a superior experience when they participate in this program.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs